Search for: "In re SMITH"
Results 1321 - 1340
of 9,534
Sorted by Relevance
|
Sort by Date
16 Nov 2010, 12:08 pm
Smith [Continued from yesterday's Part 1.] [read post]
15 Feb 2012, 6:43 am
Smith [Continued from yesterday's Part 1.] [read post]
22 Feb 2010, 8:05 am
They’re fine when you’re trying to curtail the growth of spending, but when you’re trying to impose cuts in spending, the minority can lash themselves to the majority and send everyone, struggling furiously, over the cliff. [read post]
28 Jun 2011, 3:00 am
Smith - Click here for more information on David Smith. [read post]
22 Jun 2011, 3:19 am
The Court ruled last week in Smith v. [read post]
4 Feb 2011, 11:43 am
“We’re stuck right in the middle. [read post]
20 Dec 2011, 11:42 am
Smith What makes America work? [read post]
30 Apr 2012, 8:16 am
Smith Is American household formation actually in reverse? [read post]
5 Jun 2012, 7:54 am
Smith Want to profit from the foreclosure crisis in California? [read post]
15 May 2012, 8:01 am
Smith A threat to the established order? [read post]
30 Mar 2011, 2:05 pm
No, we’re going to genuinely stabilize them. [read post]
21 Jul 2010, 11:25 am
This theme will recur – we’re used to houses having a second structure on the lot, but we’re used to that structure housing vehicles, not human beings. [read post]
16 Jul 2012, 8:41 am
Smith Look – over in Silicon Valley. [read post]
11 Jun 2012, 8:25 am
We’re solvent: don’t you wish you were? [read post]
19 Oct 2011, 7:54 am
Smith If you can’t beat it, bankrupt it? [read post]
31 Oct 2011, 10:38 am
Oh, now you’re willing to cut your spending? [read post]
14 Jun 2012, 7:25 am
Now they’re coming for the jumbo food carts. [read post]
15 Dec 2014, 6:28 am
” In re Target, supra. [read post]
11 May 2018, 3:03 am
Thoracostomy in an Auto Accident I’m Ed Smith, a Car Accident Lawyer in Sacramento. [read post]
31 Jul 2012, 7:25 am
Court of Appeals for the Third Circuit has reversed summary judgment in In re K-Dur Antitrust Litigation, and resurrected claims against defendant drug manufacturers that entered into so-called “reverse-payment” or “pay-for-delay” patent litigation settlements that allegedly delayed the sale of generic drugs. [read post]
